FDA Inspection 1201259 — AlloSource

AlloSource — FEI 3000215346

The FDA completed an inspection of AlloSource on March 30, 2023 in Centennial, CO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 30, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Centennial, CO (United States)

Citations

IDCFRDescription
1234521 CFR 1271.190(b)(1)Clean, sanitary, orderly manner
1239821 CFR 1271.230(a)Validation & approval--established procedures